VolitionRx Limited
VNRX · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | 59.1% | 153% | 240.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $14 | $20 | $15 | $13 |
| G&A Expenses | $13 | $16 | $15 | $14 |
| SG&A Expenses | $14 | $17 | $16 | $15 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $1 |
| Operating Expenses | $28 | $37 | $32 | $28 |
| Operating Income | -$27 | -$36 | -$32 | -$28 |
| % Margin | -2,190.9% | -4,641.8% | -10,372.4% | -31,469% |
| Other Income/Exp. Net | -$0 | $0 | $1 | $1 |
| Pre-Tax Income | -$27 | -$36 | -$31 | -$27 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$27 | -$35 | -$30 | -$27 |
| % Margin | -2,186.3% | -4,555.5% | -9,879.1% | -29,782.5% |
| EPS | -0.31 | -0.5 | -0.55 | -0.51 |
| % Growth | 38% | 9.1% | -7.8% | – |
| EPS Diluted | -0.31 | -0.5 | -0.55 | -0.51 |
| Weighted Avg Shares Out | 87 | 71 | 55 | 53 |
| Weighted Avg Shares Out Dil | 87 | 71 | 55 | 53 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$26 | -$34 | -$29 | -$26 |
| % Margin | -2,073.6% | -4,390.8% | -9,541.8% | -28,532% |